Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Saenko

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The Journal of Biological Chemistry|October 16, 1999
Role of factor VIII C2 domain in factor VIII binding to factor XaK Nogami, M Shima, K Hosokawa, et al.
Blood|February 7, 2001
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysisK Nogami, M Shima, J C Giddings, et al.
British Journal of Haematology|October 16, 1999
Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effectK Nogami, M Shima, H Nakai, et al.
Thrombosis and Haemostasis|October 6, 2000
An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequenceM Shibata, M Shima, S Morichika, et al.
Journal of Thrombosis and Haemostasis : JTH|January 16, 2008
Efficient factor VIII affinity purification using a small synthetic ligandS Knör, A Khrenov, B Laufer, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Journal of Biological Chemistry|October 16, 1999
Role of factor VIII C2 domain in factor VIII binding to factor XaK Nogami, M Shima, K Hosokawa, et al.
Blood|February 7, 2001
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysisK Nogami, M Shima, J C Giddings, et al.
British Journal of Haematology|October 16, 1999
Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effectK Nogami, M Shima, H Nakai, et al.
Thrombosis and Haemostasis|October 6, 2000
An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequenceM Shibata, M Shima, S Morichika, et al.
Journal of Thrombosis and Haemostasis : JTH|January 16, 2008
Efficient factor VIII affinity purification using a small synthetic ligandS Knör, A Khrenov, B Laufer, et al.
Pageof 6